| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serpins | 65 | 2021 | 205 | 14.260 |
Why?
|
| Kallikreins | 99 | 2010 | 323 | 9.140 |
Why?
|
| Tissue Kallikreins | 53 | 2015 | 106 | 8.470 |
Why?
|
| Genetic Therapy | 40 | 2013 | 291 | 3.870 |
Why?
|
| Carrier Proteins | 39 | 2006 | 597 | 3.770 |
Why?
|
| Apoptosis | 30 | 2017 | 1641 | 3.380 |
Why?
|
| Oxidative Stress | 20 | 2018 | 718 | 3.240 |
Why?
|
| Rats | 153 | 2014 | 5300 | 3.180 |
Why?
|
| Nitric Oxide Synthase Type III | 12 | 2018 | 102 | 2.880 |
Why?
|
| Neovascularization, Physiologic | 13 | 2014 | 164 | 2.830 |
Why?
|
| Kinins | 23 | 2014 | 109 | 2.750 |
Why?
|
| Kidney | 38 | 2021 | 945 | 2.740 |
Why?
|
| Adenoviridae | 44 | 2014 | 295 | 2.730 |
Why?
|
| Inflammation | 22 | 2018 | 1030 | 2.440 |
Why?
|
| Kidney Diseases | 13 | 2014 | 307 | 2.420 |
Why?
|
| Animals | 191 | 2021 | 20881 | 2.370 |
Why?
|
| Hypertension | 37 | 2016 | 1535 | 2.260 |
Why?
|
| Gene Transfer Techniques | 27 | 2009 | 173 | 2.150 |
Why?
|
| MicroRNAs | 6 | 2018 | 447 | 2.090 |
Why?
|
| Myocardial Infarction | 14 | 2013 | 807 | 1.910 |
Why?
|
| Endothelium, Vascular | 12 | 2018 | 371 | 1.910 |
Why?
|
| Receptors, Bradykinin | 15 | 2000 | 50 | 1.770 |
Why?
|
| Nitric Oxide | 17 | 2017 | 382 | 1.760 |
Why?
|
| Genetic Vectors | 33 | 2012 | 312 | 1.440 |
Why?
|
| Rats, Wistar | 28 | 2014 | 371 | 1.430 |
Why?
|
| Ventricular Remodeling | 9 | 2008 | 318 | 1.410 |
Why?
|
| Signal Transduction | 18 | 2018 | 2689 | 1.410 |
Why?
|
| Blood Pressure | 38 | 2016 | 1451 | 1.370 |
Why?
|
| Endothelial Cells | 6 | 2018 | 384 | 1.360 |
Why?
|
| Receptor, Bradykinin B2 | 14 | 2009 | 75 | 1.340 |
Why?
|
| Cell Movement | 15 | 2014 | 630 | 1.290 |
Why?
|
| Vascular System Injuries | 3 | 2018 | 20 | 1.290 |
Why?
|
| Kininogens | 16 | 1999 | 88 | 1.280 |
Why?
|
| RNA, Messenger | 50 | 2003 | 1664 | 1.270 |
Why?
|
| Cardiomegaly | 14 | 2007 | 213 | 1.260 |
Why?
|
| Peptides | 14 | 2008 | 455 | 1.200 |
Why?
|
| Sirtuin 1 | 2 | 2018 | 47 | 1.190 |
Why?
|
| Neovascularization, Pathologic | 9 | 2017 | 183 | 1.170 |
Why?
|
| Glycogen Synthase Kinase 3 | 7 | 2008 | 64 | 1.170 |
Why?
|
| Male | 124 | 2021 | 37321 | 1.150 |
Why?
|
| Recombinant Proteins | 20 | 2015 | 742 | 1.150 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2007 | 84 | 1.130 |
Why?
|
| Rats, Sprague-Dawley | 40 | 2021 | 2083 | 1.120 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 57 | 1.120 |
Why?
|
| Gene Expression | 30 | 2015 | 770 | 1.080 |
Why?
|
| Humans | 146 | 2021 | 68618 | 1.070 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2017 | 15 | 1.060 |
Why?
|
| Disease Models, Animal | 23 | 2021 | 2550 | 1.060 |
Why?
|
| Sepsis | 5 | 2017 | 233 | 1.040 |
Why?
|
| Cells, Cultured | 24 | 2017 | 2673 | 1.040 |
Why?
|
| Gene Expression Regulation | 14 | 2018 | 1293 | 1.030 |
Why?
|
| Mice | 47 | 2018 | 8474 | 0.960 |
Why?
|
| Bradykinin | 10 | 2010 | 157 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2013 | 331 | 0.900 |
Why?
|
| Fibrosis | 11 | 2021 | 371 | 0.900 |
Why?
|
| Ischemia | 6 | 2009 | 229 | 0.890 |
Why?
|
| Molecular Sequence Data | 45 | 2012 | 1447 | 0.870 |
Why?
|
| Acute Kidney Injury | 3 | 2015 | 232 | 0.870 |
Why?
|
| Rats, Inbred SHR | 25 | 2003 | 95 | 0.860 |
Why?
|
| Transforming Growth Factor beta | 9 | 2021 | 384 | 0.850 |
Why?
|
| Cellular Senescence | 3 | 2018 | 112 | 0.850 |
Why?
|
| Base Sequence | 39 | 2000 | 1015 | 0.840 |
Why?
|
| NF-kappa B | 9 | 2015 | 432 | 0.840 |
Why?
|
| Cyclic GMP | 19 | 2005 | 99 | 0.800 |
Why?
|
| Serine Endopeptidases | 11 | 2009 | 50 | 0.790 |
Why?
|
| Tumor Necrosis Factor-alpha | 12 | 2017 | 626 | 0.740 |
Why?
|
| Brain Ischemia | 6 | 2006 | 665 | 0.740 |
Why?
|
| Caenorhabditis elegans | 2 | 2017 | 38 | 0.730 |
Why?
|
| Cloning, Molecular | 28 | 2001 | 357 | 0.730 |
Why?
|
| Superoxides | 10 | 2017 | 70 | 0.720 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2013 | 63 | 0.720 |
Why?
|
| Receptor, PAR-1 | 2 | 2010 | 30 | 0.710 |
Why?
|
| Nitric Oxide Synthase | 6 | 2005 | 163 | 0.660 |
Why?
|
| Promoter Regions, Genetic | 14 | 1998 | 615 | 0.640 |
Why?
|
| Tunica Intima | 6 | 2003 | 59 | 0.630 |
Why?
|
| Myocytes, Cardiac | 9 | 2012 | 442 | 0.630 |
Why?
|
| Reperfusion Injury | 7 | 2014 | 320 | 0.630 |
Why?
|
| Blood Urea Nitrogen | 9 | 2015 | 65 | 0.620 |
Why?
|
| Rats, Inbred Dahl | 11 | 2010 | 48 | 0.620 |
Why?
|
| Amino Acid Sequence | 31 | 2012 | 1083 | 0.620 |
Why?
|
| Adrenomedullin | 11 | 2008 | 27 | 0.610 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2015 | 282 | 0.610 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2017 | 16 | 0.610 |
Why?
|
| Myocardial Ischemia | 2 | 2013 | 172 | 0.600 |
Why?
|
| Kallikrein-Kinin System | 4 | 2006 | 18 | 0.600 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 125 | 0.590 |
Why?
|
| RNA, Neoplasm | 1 | 2017 | 76 | 0.580 |
Why?
|
| Oxygen | 2 | 2017 | 386 | 0.580 |
Why?
|
| Myocardium | 12 | 2012 | 1204 | 0.570 |
Why?
|
| Blotting, Western | 23 | 2015 | 954 | 0.560 |
Why?
|
| Gentamicins | 4 | 2008 | 68 | 0.560 |
Why?
|
| Collagen | 10 | 2009 | 636 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2010 | 411 | 0.540 |
Why?
|
| DNA, Complementary | 17 | 2004 | 251 | 0.540 |
Why?
|
| Reactive Oxygen Species | 8 | 2015 | 499 | 0.540 |
Why?
|
| Wound Healing | 3 | 2010 | 260 | 0.530 |
Why?
|
| Liver | 10 | 2015 | 1118 | 0.530 |
Why?
|
| Aging | 4 | 2018 | 911 | 0.530 |
Why?
|
| Cerebrovascular Disorders | 3 | 2010 | 182 | 0.530 |
Why?
|
| Neoplasms | 2 | 2017 | 1667 | 0.530 |
Why?
|
| Cardiovascular Diseases | 4 | 2010 | 940 | 0.510 |
Why?
|
| DNA Primers | 16 | 2000 | 302 | 0.500 |
Why?
|
| Rats, Inbred Strains | 22 | 1998 | 532 | 0.500 |
Why?
|
| Caspase 3 | 8 | 2014 | 233 | 0.490 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 696 | 0.490 |
Why?
|
| beta-Galactosidase | 8 | 2018 | 88 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 756 | 0.480 |
Why?
|
| Cell Proliferation | 8 | 2016 | 1174 | 0.480 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 135 | 0.470 |
Why?
|
| NADPH Oxidases | 7 | 2017 | 80 | 0.460 |
Why?
|
| Wounds and Injuries | 2 | 2016 | 334 | 0.460 |
Why?
|
| Polymerase Chain Reaction | 18 | 2006 | 492 | 0.460 |
Why?
|
| Immunohistochemistry | 19 | 2013 | 1174 | 0.460 |
Why?
|
| Autophagy | 1 | 2016 | 208 | 0.460 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2013 | 8 | 0.450 |
Why?
|
| Hindlimb | 3 | 2009 | 38 | 0.440 |
Why?
|
| Transforming Growth Factor beta1 | 7 | 2008 | 126 | 0.440 |
Why?
|
| Hypertension, Renal | 2 | 2005 | 29 | 0.440 |
Why?
|
| Vasodilator Agents | 3 | 2007 | 138 | 0.440 |
Why?
|
| Lung | 8 | 2018 | 849 | 0.430 |
Why?
|
| Cell Line | 14 | 2015 | 1752 | 0.430 |
Why?
|
| DNA | 15 | 2004 | 597 | 0.430 |
Why?
|
| Forkhead Transcription Factors | 2 | 2010 | 94 | 0.430 |
Why?
|
| Capillaries | 7 | 2009 | 105 | 0.420 |
Why?
|
| Tissue Distribution | 19 | 2001 | 282 | 0.420 |
Why?
|
| Peptide Hormones | 2 | 2009 | 9 | 0.420 |
Why?
|
| Stroke | 7 | 2006 | 2163 | 0.420 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2010 | 33 | 0.410 |
Why?
|
| Injections, Intravenous | 10 | 2014 | 215 | 0.400 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2012 | 50 | 0.400 |
Why?
|
| Neuroprotective Agents | 5 | 2006 | 317 | 0.400 |
Why?
|
| Phosphorylation | 9 | 2010 | 1200 | 0.400 |
Why?
|
| Serine Proteinase Inhibitors | 5 | 2008 | 48 | 0.390 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2010 | 81 | 0.390 |
Why?
|
| Heart | 3 | 2008 | 850 | 0.390 |
Why?
|
| Porphyromonas gingivalis | 1 | 2011 | 33 | 0.390 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 290 | 0.380 |
Why?
|
| Nitrates | 7 | 2007 | 61 | 0.380 |
Why?
|
| Hypertrophy | 3 | 2006 | 89 | 0.370 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 160 | 0.370 |
Why?
|
| Monocytes | 1 | 2011 | 210 | 0.370 |
Why?
|
| Down-Regulation | 4 | 2015 | 447 | 0.370 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2000 | 317 | 0.370 |
Why?
|
| Proteinuria | 4 | 2006 | 136 | 0.360 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 13 | 2015 | 507 | 0.360 |
Why?
|
| Skin | 2 | 2010 | 451 | 0.350 |
Why?
|
| Submandibular Gland | 10 | 1997 | 34 | 0.350 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 25 | 0.350 |
Why?
|
| Receptor, Bradykinin B1 | 8 | 2007 | 25 | 0.350 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 498 | 0.340 |
Why?
|
| Aorta | 4 | 2010 | 316 | 0.340 |
Why?
|
| alpha 1-Antitrypsin | 6 | 2000 | 61 | 0.340 |
Why?
|
| Blood Vessels | 2 | 2001 | 102 | 0.340 |
Why?
|
| Keratinocytes | 1 | 2009 | 68 | 0.340 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1070 | 0.340 |
Why?
|
| Hydrogen Peroxide | 4 | 2018 | 168 | 0.330 |
Why?
|
| Cyclic AMP | 9 | 2003 | 223 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 1536 | 0.320 |
Why?
|
| Atrial Natriuretic Factor | 7 | 2004 | 54 | 0.320 |
Why?
|
| Arthritis, Experimental | 2 | 2007 | 38 | 0.320 |
Why?
|
| Kidney Glomerulus | 2 | 2008 | 155 | 0.320 |
Why?
|
| Antioxidants | 2 | 2008 | 304 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 8 | 2013 | 219 | 0.320 |
Why?
|
| Multienzyme Complexes | 5 | 2012 | 50 | 0.310 |
Why?
|
| Prostate | 4 | 1995 | 116 | 0.310 |
Why?
|
| Nephritis, Interstitial | 1 | 2008 | 14 | 0.310 |
Why?
|
| Muscle, Skeletal | 3 | 2009 | 396 | 0.310 |
Why?
|
| ErbB Receptors | 1 | 2009 | 239 | 0.310 |
Why?
|
| Salivary Glands | 2 | 1998 | 52 | 0.300 |
Why?
|
| Sodium Chloride | 5 | 2008 | 136 | 0.300 |
Why?
|
| Catalase | 3 | 2018 | 85 | 0.300 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 51 | 0.300 |
Why?
|
| Mesangial Cells | 1 | 2008 | 37 | 0.300 |
Why?
|
| NADH, NADPH Oxidoreductases | 4 | 2012 | 19 | 0.300 |
Why?
|
| Neuropeptides | 1 | 2008 | 106 | 0.300 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 6 | 2008 | 57 | 0.300 |
Why?
|
| Transfection | 12 | 2010 | 782 | 0.300 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2017 | 21 | 0.290 |
Why?
|
| Angioplasty, Balloon | 4 | 2003 | 110 | 0.290 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 52 | 0.290 |
Why?
|
| Myocarditis | 1 | 2007 | 49 | 0.290 |
Why?
|
| Chemokine CCL2 | 4 | 2009 | 101 | 0.290 |
Why?
|
| In Situ Hybridization | 9 | 2001 | 201 | 0.290 |
Why?
|
| Telomerase | 2 | 2018 | 85 | 0.290 |
Why?
|
| Salvage Therapy | 1 | 2007 | 82 | 0.290 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 2017 | 58 | 0.290 |
Why?
|
| Female | 38 | 2021 | 38074 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 2 | 2008 | 1026 | 0.280 |
Why?
|
| Interleukin-6 | 5 | 2015 | 330 | 0.280 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2003 | 204 | 0.280 |
Why?
|
| Kinetics | 11 | 2001 | 1047 | 0.280 |
Why?
|
| Sequence Homology, Amino Acid | 12 | 2001 | 231 | 0.280 |
Why?
|
| Protein Binding | 7 | 2013 | 1027 | 0.270 |
Why?
|
| Desoxycorticosterone | 5 | 2012 | 41 | 0.270 |
Why?
|
| Carboxylic Ester Hydrolases | 5 | 1992 | 26 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 710 | 0.270 |
Why?
|
| Endotoxemia | 2 | 2015 | 27 | 0.270 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 157 | 0.270 |
Why?
|
| Hypotension | 6 | 1997 | 74 | 0.270 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 778 | 0.270 |
Why?
|
| Molecular Weight | 12 | 1996 | 358 | 0.270 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2017 | 195 | 0.270 |
Why?
|
| Laminin | 4 | 2009 | 62 | 0.270 |
Why?
|
| HEK293 Cells | 2 | 2018 | 326 | 0.260 |
Why?
|
| Caspases | 6 | 2005 | 194 | 0.260 |
Why?
|
| Cell Division | 6 | 2005 | 541 | 0.260 |
Why?
|
| Proteoglycans | 4 | 2009 | 103 | 0.260 |
Why?
|
| Isoenzymes | 1 | 2006 | 308 | 0.250 |
Why?
|
| Adenoviruses, Human | 1 | 2005 | 12 | 0.250 |
Why?
|
| Cell Survival | 5 | 2014 | 901 | 0.250 |
Why?
|
| Rats, Inbred WKY | 10 | 2003 | 48 | 0.250 |
Why?
|
| Gene Library | 5 | 2009 | 68 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2011 | 1745 | 0.250 |
Why?
|
| Drug Combinations | 4 | 2009 | 304 | 0.250 |
Why?
|
| 14-3-3 Proteins | 1 | 2004 | 12 | 0.250 |
Why?
|
| Nitrites | 5 | 2007 | 53 | 0.250 |
Why?
|
| HMGB1 Protein | 2 | 2015 | 23 | 0.250 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2006 | 140 | 0.240 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 11 | 2000 | 272 | 0.240 |
Why?
|
| Biomarkers | 6 | 2017 | 1593 | 0.240 |
Why?
|
| Plasmids | 6 | 2010 | 258 | 0.240 |
Why?
|
| Transcription, Genetic | 8 | 1997 | 562 | 0.240 |
Why?
|
| Heparin | 3 | 2001 | 205 | 0.240 |
Why?
|
| Recovery of Function | 1 | 2008 | 506 | 0.240 |
Why?
|
| Receptors, Immunologic | 4 | 1993 | 72 | 0.240 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1851 | 0.230 |
Why?
|
| Binding Sites | 10 | 2001 | 631 | 0.230 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 114 | 0.230 |
Why?
|
| Colon | 2 | 1995 | 168 | 0.230 |
Why?
|
| Models, Animal | 4 | 2010 | 252 | 0.230 |
Why?
|
| Mice, Knockout | 4 | 2018 | 1692 | 0.230 |
Why?
|
| Neuroglia | 2 | 2003 | 136 | 0.230 |
Why?
|
| Mice, Transgenic | 12 | 2006 | 1033 | 0.230 |
Why?
|
| Carotid Arteries | 3 | 2003 | 110 | 0.230 |
Why?
|
| NADP | 3 | 2010 | 39 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2007 | 250 | 0.220 |
Why?
|
| Adrenal Glands | 2 | 1996 | 46 | 0.220 |
Why?
|
| Potassium | 4 | 2012 | 168 | 0.220 |
Why?
|
| Creatinine | 3 | 2015 | 243 | 0.220 |
Why?
|
| Stem Cells | 3 | 2013 | 248 | 0.210 |
Why?
|
| Aprotinin | 5 | 2010 | 55 | 0.210 |
Why?
|
| Chromosome Mapping | 5 | 1997 | 188 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2008 | 201 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 7 | 1999 | 511 | 0.210 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 1851 | 0.210 |
Why?
|
| Cerebral Infarction | 5 | 2006 | 103 | 0.210 |
Why?
|
| Streptozocin | 3 | 2017 | 34 | 0.210 |
Why?
|
| Blotting, Northern | 9 | 1999 | 189 | 0.210 |
Why?
|
| Lipopolysaccharides | 6 | 2015 | 455 | 0.210 |
Why?
|
| Hypertension, Renovascular | 2 | 2001 | 47 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2003 | 475 | 0.200 |
Why?
|
| Enzyme Activation | 4 | 2011 | 791 | 0.200 |
Why?
|
| Peptidyl-Dipeptidase A | 6 | 1992 | 38 | 0.190 |
Why?
|
| Injections, Subcutaneous | 4 | 2008 | 87 | 0.190 |
Why?
|
| Renal Circulation | 2 | 2000 | 49 | 0.190 |
Why?
|
| Blotting, Southern | 10 | 1999 | 67 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 2791 | 0.190 |
Why?
|
| Ureteral Obstruction | 1 | 2021 | 25 | 0.190 |
Why?
|
| Antigens | 2 | 1993 | 90 | 0.190 |
Why?
|
| Cytomegalovirus | 6 | 1998 | 63 | 0.190 |
Why?
|
| Radioimmunoassay | 11 | 2001 | 164 | 0.190 |
Why?
|
| Time Factors | 12 | 2009 | 4655 | 0.180 |
Why?
|
| In Vitro Techniques | 3 | 2014 | 765 | 0.180 |
Why?
|
| Transduction, Genetic | 2 | 2013 | 81 | 0.180 |
Why?
|
| Brain | 9 | 2006 | 2176 | 0.180 |
Why?
|
| Sequence Homology, Nucleic Acid | 11 | 1997 | 95 | 0.180 |
Why?
|
| Umbilical Veins | 2 | 2010 | 54 | 0.180 |
Why?
|
| Enzyme Inhibitors | 4 | 2009 | 659 | 0.170 |
Why?
|
| Genes | 4 | 1997 | 86 | 0.170 |
Why?
|
| Catheterization | 1 | 2000 | 209 | 0.170 |
Why?
|
| Avian Sarcoma Viruses | 7 | 1999 | 20 | 0.170 |
Why?
|
| Organ Specificity | 7 | 1999 | 167 | 0.170 |
Why?
|
| Arteries | 1 | 2000 | 108 | 0.170 |
Why?
|
| Eye | 2 | 1996 | 89 | 0.170 |
Why?
|
| Diabetic Retinopathy | 2 | 1997 | 110 | 0.170 |
Why?
|
| Transgenes | 4 | 2013 | 92 | 0.170 |
Why?
|
| DNA, Recombinant | 3 | 1997 | 25 | 0.160 |
Why?
|
| Arterioles | 2 | 2009 | 40 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 161 | 0.160 |
Why?
|
| Restriction Mapping | 9 | 1997 | 85 | 0.160 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 63 | 0.160 |
Why?
|
| Serpin E2 | 1 | 2018 | 8 | 0.160 |
Why?
|
| Multigene Family | 7 | 1993 | 93 | 0.160 |
Why?
|
| Pancreas | 3 | 1998 | 225 | 0.160 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2009 | 45 | 0.160 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 56 | 0.160 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 45 | 0.160 |
Why?
|
| Bradykinin B2 Receptor Antagonists | 2 | 2008 | 13 | 0.160 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2018 | 41 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2001 | 332 | 0.150 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2009 | 12 | 0.150 |
Why?
|
| Luciferases | 2 | 2010 | 105 | 0.150 |
Why?
|
| Alanine Transaminase | 2 | 2015 | 137 | 0.150 |
Why?
|
| RNA, Helminth | 1 | 2017 | 4 | 0.150 |
Why?
|
| Osteoarthritis | 2 | 2009 | 73 | 0.150 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2007 | 23 | 0.150 |
Why?
|
| Ligation | 2 | 2009 | 83 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 3 | 2010 | 369 | 0.150 |
Why?
|
| Sirtuins | 1 | 2017 | 16 | 0.150 |
Why?
|
| Genistein | 1 | 2017 | 26 | 0.150 |
Why?
|
| Aged | 9 | 2021 | 14862 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2000 | 365 | 0.140 |
Why?
|
| Protease Inhibitors | 3 | 2011 | 76 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2008 | 52 | 0.140 |
Why?
|
| Cyclosporine | 1 | 1997 | 121 | 0.140 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 60 | 0.140 |
Why?
|
| Shock, Septic | 1 | 2017 | 101 | 0.140 |
Why?
|
| Hemodynamics | 3 | 2007 | 705 | 0.140 |
Why?
|
| Enzyme Precursors | 3 | 2011 | 27 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 175 | 0.140 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2005 | 160 | 0.140 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1996 | 8 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 1998 | 121 | 0.140 |
Why?
|
| Spleen | 3 | 2014 | 301 | 0.140 |
Why?
|
| Regional Blood Flow | 3 | 2008 | 168 | 0.140 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1996 | 45 | 0.140 |
Why?
|
| Blood Cells | 1 | 1996 | 27 | 0.140 |
Why?
|
| Body Fluids | 1 | 1996 | 41 | 0.140 |
Why?
|
| Parotid Gland | 2 | 1994 | 33 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 18 | 0.140 |
Why?
|
| Models, Molecular | 5 | 2001 | 546 | 0.130 |
Why?
|
| Isoelectric Focusing | 6 | 1992 | 42 | 0.130 |
Why?
|
| Hemagglutinins, Viral | 1 | 2015 | 2 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 328 | 0.130 |
Why?
|
| Snail Family Transcription Factors | 1 | 2015 | 31 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2015 | 12 | 0.130 |
Why?
|
| Protein Conformation | 3 | 2001 | 362 | 0.130 |
Why?
|
| Aorta, Thoracic | 1 | 1997 | 211 | 0.130 |
Why?
|
| Lac Operon | 4 | 1999 | 54 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 12 | 0.130 |
Why?
|
| Middle Aged | 10 | 2021 | 21147 | 0.130 |
Why?
|
| NAD | 2 | 2006 | 73 | 0.130 |
Why?
|
| Disease Progression | 2 | 2017 | 1038 | 0.130 |
Why?
|
| Malondialdehyde | 1 | 2015 | 43 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2005 | 38 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 248 | 0.120 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 35 | 0.120 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1997 | 72 | 0.120 |
Why?
|
| Hemoglobins | 2 | 2008 | 120 | 0.120 |
Why?
|
| Catalytic Domain | 1 | 2015 | 99 | 0.120 |
Why?
|
| Culture Media, Conditioned | 2 | 2011 | 78 | 0.120 |
Why?
|
| DNA Probes | 5 | 1996 | 57 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2015 | 79 | 0.120 |
Why?
|
| Semen | 1 | 1994 | 29 | 0.120 |
Why?
|
| Prognosis | 2 | 2017 | 2093 | 0.120 |
Why?
|
| Creatine | 1 | 2014 | 30 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2015 | 753 | 0.120 |
Why?
|
| Macrophages | 2 | 2015 | 647 | 0.120 |
Why?
|
| Bradykinin Receptor Antagonists | 3 | 2000 | 20 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2007 | 223 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 240 | 0.120 |
Why?
|
| Rats, Inbred BN | 2 | 2008 | 51 | 0.120 |
Why?
|
| Epithelial Sodium Channels | 2 | 2012 | 25 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2005 | 194 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2014 | 1040 | 0.110 |
Why?
|
| Salts | 2 | 2006 | 21 | 0.110 |
Why?
|
| Coronary Vessels | 2 | 2007 | 313 | 0.110 |
Why?
|
| Heart Ventricles | 3 | 2007 | 738 | 0.110 |
Why?
|
| Genes, Reporter | 4 | 1998 | 191 | 0.110 |
Why?
|
| Streptococcus pyogenes | 1 | 2013 | 20 | 0.110 |
Why?
|
| Monocrotaline | 1 | 1993 | 4 | 0.110 |
Why?
|
| Wnt3A Protein | 1 | 2013 | 6 | 0.110 |
Why?
|
| Asialoglycoprotein Receptor | 5 | 1996 | 11 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2013 | 35 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2014 | 489 | 0.110 |
Why?
|
| Cyclin D1 | 1 | 2013 | 37 | 0.110 |
Why?
|
| Streptococcal Infections | 1 | 2013 | 53 | 0.110 |
Why?
|
| Up-Regulation | 4 | 2013 | 682 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2015 | 211 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 230 | 0.110 |
Why?
|
| Antibodies | 2 | 2010 | 241 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2008 | 902 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 58 | 0.110 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 25 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 4 | 1998 | 376 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 90 | 0.110 |
Why?
|
| Escherichia coli | 5 | 1997 | 368 | 0.110 |
Why?
|
| Lymphokines | 2 | 2003 | 49 | 0.110 |
Why?
|
| Hypoxia | 2 | 2004 | 169 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 4 | 1997 | 208 | 0.100 |
Why?
|
| Neutrophils | 1 | 2013 | 204 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 94 | 0.100 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 122 | 0.100 |
Why?
|
| Dipeptides | 2 | 2011 | 89 | 0.100 |
Why?
|
| Pneumonia | 1 | 2013 | 110 | 0.100 |
Why?
|
| Leupeptins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2011 | 23 | 0.100 |
Why?
|
| Chromatography, Ion Exchange | 5 | 1993 | 73 | 0.100 |
Why?
|
| Cathepsins | 1 | 2011 | 37 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2011 | 48 | 0.100 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 137 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 59 | 0.100 |
Why?
|
| Kidney Function Tests | 3 | 2004 | 114 | 0.100 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2011 | 59 | 0.100 |
Why?
|
| Survival Rate | 1 | 2014 | 1056 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2011 | 73 | 0.100 |
Why?
|
| Progesterone | 1 | 1992 | 115 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2014 | 276 | 0.100 |
Why?
|
| Estrogens | 1 | 1992 | 173 | 0.090 |
Why?
|
| Kidney Tubules | 2 | 2008 | 80 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2010 | 617 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 189 | 0.090 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2010 | 11 | 0.090 |
Why?
|
| Protein Structure, Secondary | 2 | 2001 | 136 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2001 | 137 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 1993 | 232 | 0.090 |
Why?
|
| Lentivirus | 1 | 2010 | 35 | 0.090 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 20 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1753 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 100 | 0.090 |
Why?
|
| Systole | 4 | 2000 | 149 | 0.090 |
Why?
|
| Myocardial Contraction | 2 | 2012 | 383 | 0.090 |
Why?
|
| Rats, Inbred WF | 1 | 2010 | 14 | 0.090 |
Why?
|
| Metalloproteases | 1 | 2010 | 9 | 0.090 |
Why?
|
| Carotid Artery Injuries | 2 | 2000 | 26 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 20 | 0.090 |
Why?
|
| Injections, Intramuscular | 3 | 1999 | 44 | 0.090 |
Why?
|
| Arthritis | 1 | 2010 | 53 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2016 | 2007 | 0.090 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 26 | 0.090 |
Why?
|
| DNA, Viral | 2 | 2002 | 114 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2003 | 239 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 852 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 2 | 2007 | 25 | 0.090 |
Why?
|
| Natriuresis | 1 | 2009 | 13 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2009 | 94 | 0.080 |
Why?
|
| Constriction, Pathologic | 2 | 2000 | 236 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 196 | 0.080 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2009 | 16 | 0.080 |
Why?
|
| Angiotensin II | 1 | 2010 | 220 | 0.080 |
Why?
|
| Heart Atria | 1 | 1989 | 206 | 0.080 |
Why?
|
| Vasodilation | 2 | 2000 | 85 | 0.080 |
Why?
|
| Brain Infarction | 2 | 2006 | 54 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 226 | 0.080 |
Why?
|
| Femoral Artery | 1 | 2009 | 139 | 0.080 |
Why?
|
| Peroxidase | 1 | 2008 | 40 | 0.080 |
Why?
|
| Bradykinin B1 Receptor Antagonists | 1 | 2008 | 2 | 0.080 |
Why?
|
| Ligands | 1 | 2009 | 317 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 32 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2009 | 270 | 0.080 |
Why?
|
| Nitrogen Oxides | 1 | 2008 | 7 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 174 | 0.080 |
Why?
|
| Microspheres | 1 | 2008 | 59 | 0.080 |
Why?
|
| Drug Antagonism | 1 | 2008 | 6 | 0.080 |
Why?
|
| Reference Values | 3 | 1999 | 579 | 0.080 |
Why?
|
| Lasers | 1 | 2008 | 61 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2009 | 525 | 0.080 |
Why?
|
| Body Weight | 4 | 1999 | 554 | 0.080 |
Why?
|
| Injections | 1 | 2008 | 119 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 100 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 223 | 0.080 |
Why?
|
| Perfusion | 1 | 2008 | 131 | 0.080 |
Why?
|
| Fixatives | 1 | 1987 | 24 | 0.080 |
Why?
|
| Injections, Intraventricular | 2 | 1998 | 50 | 0.080 |
Why?
|
| Heart Function Tests | 1 | 2007 | 33 | 0.080 |
Why?
|
| Synovial Fluid | 1 | 2007 | 16 | 0.080 |
Why?
|
| Hyperinsulinism | 2 | 2007 | 23 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 1998 | 165 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 694 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 134 | 0.070 |
Why?
|
| Aldosterone | 2 | 2009 | 51 | 0.070 |
Why?
|
| Infusion Pumps | 1 | 2007 | 39 | 0.070 |
Why?
|
| Neurons | 2 | 2006 | 881 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 1999 | 396 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1997 | 38 | 0.070 |
Why?
|
| Metallothionein | 2 | 1997 | 20 | 0.070 |
Why?
|
| Organ Size | 2 | 2005 | 242 | 0.070 |
Why?
|
| Caspase Inhibitors | 1 | 2006 | 36 | 0.070 |
Why?
|
| Dogs | 2 | 2015 | 490 | 0.070 |
Why?
|
| Exons | 6 | 1996 | 122 | 0.070 |
Why?
|
| Myoblasts, Smooth Muscle | 1 | 2006 | 2 | 0.070 |
Why?
|
| Reticulin | 1 | 2006 | 3 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2003 | 30 | 0.070 |
Why?
|
| Arginine | 2 | 1997 | 102 | 0.070 |
Why?
|
| Receptors, Peptide | 1 | 2006 | 32 | 0.070 |
Why?
|
| Heart Rate | 2 | 1999 | 568 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 35 | 0.070 |
Why?
|
| Urinary Bladder Diseases | 1 | 2006 | 26 | 0.070 |
Why?
|
| Actins | 2 | 2006 | 249 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1997 | 189 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2005 | 254 | 0.070 |
Why?
|
| Protein Transport | 1 | 2006 | 280 | 0.070 |
Why?
|
| Sodium | 4 | 2012 | 161 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2016 | 7029 | 0.070 |
Why?
|
| Introns | 6 | 1996 | 68 | 0.070 |
Why?
|
| Carotid Stenosis | 2 | 2004 | 163 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2006 | 305 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 1997 | 176 | 0.060 |
Why?
|
| Adult | 8 | 2021 | 21403 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 161 | 0.060 |
Why?
|
| Substrate Specificity | 4 | 1992 | 234 | 0.060 |
Why?
|
| Autoantibodies | 1 | 1988 | 434 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1991 | 381 | 0.060 |
Why?
|
| Joints | 1 | 2005 | 30 | 0.060 |
Why?
|
| Azo Compounds | 1 | 2005 | 33 | 0.060 |
Why?
|
| bcl-Associated Death Protein | 1 | 2004 | 19 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2007 | 241 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 1998 | 165 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2004 | 51 | 0.060 |
Why?
|
| Genomic Library | 2 | 1994 | 18 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 1991 | 551 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 82 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 85 | 0.060 |
Why?
|
| Ventricular Function | 1 | 2005 | 93 | 0.060 |
Why?
|
| Spinal Cord | 2 | 1999 | 244 | 0.060 |
Why?
|
| Lithium | 1 | 2004 | 76 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 142 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2008 | 220 | 0.060 |
Why?
|
| Retina | 2 | 1997 | 252 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 132 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1997 | 44 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 4848 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 234 | 0.060 |
Why?
|
| Cardiomyopathies | 2 | 2005 | 167 | 0.060 |
Why?
|
| Pancreatic Elastase | 2 | 1996 | 33 | 0.060 |
Why?
|
| Albuminuria | 1 | 2004 | 171 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1996 | 26 | 0.060 |
Why?
|
| Software | 2 | 2001 | 418 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2004 | 175 | 0.060 |
Why?
|
| Kidney Cortex | 2 | 1996 | 19 | 0.060 |
Why?
|
| Lipids | 1 | 2005 | 298 | 0.060 |
Why?
|
| Endothelium | 1 | 2003 | 98 | 0.060 |
Why?
|
| Interleukin-1 | 2 | 2006 | 86 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2005 | 631 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2003 | 136 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2009 | 824 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 146 | 0.050 |
Why?
|
| Cytoplasmic Granules | 2 | 1994 | 19 | 0.050 |
Why?
|
| Astrocytes | 1 | 2004 | 270 | 0.050 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 134 | 0.050 |
Why?
|
| Sodium Channels | 1 | 2001 | 24 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 493 | 0.050 |
Why?
|
| Proteome | 1 | 2002 | 87 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1990 | 95 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1173 | 0.050 |
Why?
|
| Autoradiography | 2 | 1993 | 94 | 0.050 |
Why?
|
| Nasal Mucosa | 1 | 2001 | 68 | 0.050 |
Why?
|
| Hydroxyapatites | 2 | 1992 | 10 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 1996 | 295 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 419 | 0.050 |
Why?
|
| Chromatography | 2 | 1992 | 47 | 0.050 |
Why?
|
| Sex Factors | 3 | 1997 | 1266 | 0.050 |
Why?
|
| Durapatite | 2 | 1992 | 33 | 0.050 |
Why?
|
| Calorimetry | 1 | 2000 | 21 | 0.050 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2001 | 43 | 0.050 |
Why?
|
| Pregnancy | 2 | 1997 | 2334 | 0.050 |
Why?
|
| Ovariectomy | 2 | 1992 | 49 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2001 | 99 | 0.050 |
Why?
|
| Insulin | 3 | 2003 | 619 | 0.050 |
Why?
|
| beta Catenin | 1 | 2021 | 73 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 191 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 415 | 0.050 |
Why?
|
| Acute-Phase Reaction | 2 | 1992 | 10 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2000 | 25 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2000 | 48 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 1997 | 89 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 1999 | 329 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 45 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1997 | 37 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2000 | 103 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 1999 | 20 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 2000 | 179 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 532 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1999 | 29 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1992 | 618 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2000 | 79 | 0.040 |
Why?
|
| Tunica Media | 1 | 1999 | 33 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 247 | 0.040 |
Why?
|
| Carotid Artery, Common | 1 | 1999 | 25 | 0.040 |
Why?
|
| Molecular Probes | 2 | 1996 | 27 | 0.040 |
Why?
|
| Heart Failure | 1 | 2008 | 1180 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 508 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 97 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 351 | 0.040 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 180 | 0.040 |
Why?
|
| Cross Reactions | 2 | 1988 | 57 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 107 | 0.040 |
Why?
|
| Rabbits | 1 | 1998 | 509 | 0.040 |
Why?
|
| Oocytes | 2 | 2012 | 57 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 1998 | 159 | 0.040 |
Why?
|
| Gene Dosage | 1 | 1997 | 47 | 0.040 |
Why?
|
| Drinking | 1 | 1997 | 35 | 0.040 |
Why?
|
| Taiwan | 1 | 2017 | 20 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2017 | 3705 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 89 | 0.040 |
Why?
|
| Point Mutation | 1 | 1997 | 97 | 0.040 |
Why?
|
| Codon | 2 | 1994 | 21 | 0.040 |
Why?
|
| Blood Proteins | 1 | 1997 | 94 | 0.040 |
Why?
|
| Uterine Contraction | 1 | 1997 | 30 | 0.040 |
Why?
|
| Kallidin | 1 | 1996 | 9 | 0.040 |
Why?
|
| Vitreous Body | 1 | 1996 | 26 | 0.030 |
Why?
|
| Virus Replication | 1 | 1997 | 104 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 334 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1996 | 11 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1997 | 210 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 117 | 0.030 |
Why?
|
| Kidney Medulla | 1 | 1996 | 17 | 0.030 |
Why?
|
| Cattle | 1 | 1997 | 475 | 0.030 |
Why?
|
| Homeostasis | 1 | 1998 | 291 | 0.030 |
Why?
|
| Choroid | 1 | 1996 | 22 | 0.030 |
Why?
|
| Ciliary Body | 1 | 1996 | 52 | 0.030 |
Why?
|
| Portal Vein | 1 | 1996 | 46 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1993 | 73 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1997 | 150 | 0.030 |
Why?
|
| Optic Nerve | 1 | 1996 | 55 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 301 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 2003 | 98 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 536 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1996 | 223 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 1996 | 85 | 0.030 |
Why?
|
| Critical Illness | 1 | 2017 | 191 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2015 | 64 | 0.030 |
Why?
|
| fas Receptor | 1 | 2015 | 54 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1996 | 110 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2015 | 117 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 1997 | 323 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 792 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2017 | 344 | 0.030 |
Why?
|
| Trypsin Inhibitors | 2 | 1992 | 15 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1996 | 206 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 1994 | 27 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1994 | 61 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 138 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 27 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1996 | 193 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 87 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1994 | 49 | 0.030 |
Why?
|
| Phenotype | 1 | 1997 | 947 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1994 | 75 | 0.030 |
Why?
|
| Antibody Formation | 2 | 1997 | 93 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 35 | 0.030 |
Why?
|
| Growth Hormone | 2 | 1996 | 51 | 0.030 |
Why?
|
| Asialoglycoproteins | 1 | 1993 | 4 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 88 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2013 | 41 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1993 | 63 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2015 | 431 | 0.030 |
Why?
|
| Alleles | 2 | 2008 | 386 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2013 | 131 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2013 | 46 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 2013 | 46 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 314 | 0.030 |
Why?
|
| Angiotensin I | 1 | 1992 | 24 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 1992 | 18 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 1992 | 48 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2012 | 35 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 294 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2012 | 60 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2015 | 296 | 0.030 |
Why?
|
| Growth | 1 | 1992 | 17 | 0.030 |
Why?
|
| Renin | 1 | 1992 | 96 | 0.030 |
Why?
|
| Mortality | 1 | 2013 | 163 | 0.030 |
Why?
|
| Urine | 2 | 2003 | 47 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 442 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 1992 | 322 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1992 | 52 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 714 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 79 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 1996 | 144 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1991 | 238 | 0.020 |
Why?
|
| Base Composition | 1 | 1990 | 22 | 0.020 |
Why?
|
| Lectins | 1 | 1990 | 81 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1991 | 173 | 0.020 |
Why?
|
| Turpentine | 1 | 1989 | 2 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 1989 | 11 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 304 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2009 | 27 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1989 | 17 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 2003 | 134 | 0.020 |
Why?
|
| Esterases | 1 | 1988 | 9 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 34 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1989 | 119 | 0.020 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2009 | 32 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 97 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 244 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1988 | 137 | 0.020 |
Why?
|
| Knee Joint | 1 | 2009 | 115 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 1988 | 34 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1990 | 358 | 0.020 |
Why?
|
| Exocrine Glands | 1 | 1987 | 5 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1988 | 124 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1988 | 196 | 0.020 |
Why?
|
| Immune Sera | 1 | 1987 | 30 | 0.020 |
Why?
|
| Prolactin | 1 | 1988 | 61 | 0.020 |
Why?
|
| RNA | 1 | 1989 | 171 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1034 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1987 | 119 | 0.020 |
Why?
|
| Estradiol | 1 | 1989 | 176 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1989 | 284 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1989 | 167 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1987 | 94 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2007 | 48 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 150 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2004 | 3259 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 147 | 0.020 |
Why?
|
| Urothelium | 1 | 2006 | 22 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 786 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 8912 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2005 | 46 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 92 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2005 | 107 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 160 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 1996 | 16 | 0.020 |
Why?
|
| Glycogen | 1 | 2005 | 27 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2005 | 289 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2006 | 241 | 0.020 |
Why?
|
| Protein Biosynthesis | 3 | 1991 | 181 | 0.020 |
Why?
|
| Age Factors | 2 | 2001 | 1864 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 161 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 262 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 48 | 0.010 |
Why?
|
| Receptors, Endothelin | 1 | 2003 | 30 | 0.010 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2003 | 10 | 0.010 |
Why?
|
| Oxadiazoles | 1 | 2003 | 7 | 0.010 |
Why?
|
| Nitroso Compounds | 1 | 2003 | 16 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 88 | 0.010 |
Why?
|
| Fructose | 1 | 2003 | 51 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 337 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2003 | 80 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2004 | 110 | 0.010 |
Why?
|
| Quinoxalines | 1 | 2003 | 78 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 43 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 50 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 324 | 0.010 |
Why?
|
| S-Nitrosoglutathione | 1 | 2003 | 87 | 0.010 |
Why?
|
| Xenopus | 1 | 2001 | 30 | 0.010 |
Why?
|
| TATA Box | 2 | 1991 | 7 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 453 | 0.010 |
Why?
|
| Trypsin | 1 | 2001 | 64 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2001 | 160 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 5717 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2002 | 50 | 0.010 |
Why?
|
| Amino Acids | 1 | 2001 | 131 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1465 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1553 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1999 | 14 | 0.010 |
Why?
|
| Posterior Horn Cells | 1 | 1999 | 4 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 306 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1999 | 33 | 0.010 |
Why?
|
| Brain Stem | 1 | 1999 | 46 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1999 | 150 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1999 | 77 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1999 | 24 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 981 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 1998 | 31 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 1085 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1998 | 274 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 481 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1997 | 235 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1996 | 43 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 63 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1996 | 237 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1994 | 30 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1994 | 97 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 303 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1994 | 120 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1994 | 258 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1992 | 11 | 0.010 |
Why?
|
| Haplorhini | 1 | 1992 | 44 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1991 | 105 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1992 | 420 | 0.010 |
Why?
|
| Detergents | 1 | 1991 | 34 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1992 | 86 | 0.010 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1990 | 4 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1992 | 483 | 0.010 |
Why?
|
| Genome, Human | 1 | 1990 | 62 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 35 | 0.010 |
Why?
|
| Thromboxanes | 1 | 1989 | 53 | 0.010 |
Why?
|
| Fish Oils | 1 | 1989 | 21 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1989 | 65 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 49 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1988 | 25 | 0.010 |
Why?
|
| Thyroxine | 1 | 1988 | 62 | 0.000 |
Why?
|
| Testosterone | 1 | 1988 | 96 | 0.000 |
Why?
|
| Superoxide Dismutase | 1 | 1989 | 149 | 0.000 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1988 | 10 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1987 | 16 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1987 | 43 | 0.000 |
Why?
|
| Pituitary Neoplasms | 1 | 1988 | 52 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1989 | 296 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1987 | 82 | 0.000 |
Why?
|
| Muscles | 1 | 1987 | 158 | 0.000 |
Why?
|